APJ is a seven transmembrane domain G-protein-coupled receptor that functio
ns as a coreceptor for some primate immunodeficiency virus strains. The in
vivo significance of APJ coreceptor function remains to be elucidated, howe
ver, due to the lack of an antibody that can be used to assess API expressi
on, and because of the absence of an antibody or ligand that can block APJ
coreceptor activity. Therefore, we produced a specific monoclonal antibody
(MAb 856) to APJ and found that it detected this receptor in FAGS, immunofl
uorescence, and immunohistochemistry studies. MAb 856 also recognized API b
y Western blot, enabling us to determine that APJ is N-glycosylated. Using
this antibody, we correlated APJ expression with coreceptor activity and fo
und that APJ had coreceptor function even at low levels of expression. Howe
ver, we found that API could not be detected by FAGS analysis on cell lines
commonly used to propagate primate lentiviruses, nor was it expressed on h
uman PBMC cultured under a variety of conditions. We also found that some v
iral envelope proteins could mediate fusion with APJ-positive, CD4-negative
cells, provided that CD4 was added in trans. These findings indicate that
in some situations APJ use could render primary cell types susceptible to v
irus infection, although we have not found any evidence that this occurs. F
inally, the peptide ligand for APJ, apelin-13, efficiently blocked APJ core
ceptor activity. (C) 2000 Academic Press.